Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) IPO

Cadrenal Therapeutics, Inc.

IPO

Priced at US$5.00 a share on Jan 19, 2023.

Price
US$5.00 a share
Shares offered
3,104,783 shares of common stock · 1,400,000 from the company and 1,704,783 from selling shareholders
Offering size
US$7 million
Underwriters' option
Up to 210,000 more shares
Listing
CVKD on the Nasdaq Capital Market
Underwriters
Boustead Securities, LLC, Sutter Securities, Inc., Revere Securities LLC · In the order on the cover
Shares delivered
On or about Jan 24, 2023

Steps

StepWhen
Draft sent to the SEC in confidenceJul 15, 2022
Filed publiclySep 22, 2022
Amended 6 timesNewest Jan 17, 2023
Shares registered with an exchangeJan 17, 2023
Declared effective by the SECJan 19, 2023
Final prospectus, with the priceJan 23, 2023

From the cover of the final prospectus (424B4) filed Jan 23, 2023